Pages that link to "Q26752522"
Jump to navigation
Jump to search
The following pages link to Vaccine adjuvants as potential cancer immunotherapeutics (Q26752522):
Displaying 50 items.
- Immunotherapy of Malignant Tumors in the Brain: How Different from Other Sites? (Q28078539) (← links)
- The anti-influenza M2e antibody response is promoted by XCR1 targeting in pig skin. (Q38369004) (← links)
- Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors (Q38742968) (← links)
- Current status and future prospects of peptide-based cancer vaccines (Q38780728) (← links)
- Delivery of therapeutics with nanoparticles: what's new in cancer immunotherapy? (Q38912004) (← links)
- The revival of cancer vaccines - The eminent need to activate humoral immunity (Q39001905) (← links)
- Engaging Natural Killer T Cells as 'Universal Helpers' for Vaccination (Q39049093) (← links)
- Intralesional treatment of metastatic melanoma: a review of therapeutic options (Q39081034) (← links)
- Myeloid-derived cells in prostate cancer progression: phenotype and prospective therapies. (Q39333529) (← links)
- Glycolipid-peptide conjugate vaccines enhance CD8+ T cell responses against human viral proteins (Q47144502) (← links)
- Enhancement of therapeutic DNA vaccine potency by melatonin through inhibiting VEGF expression and induction of antitumor immunity mediated by CD8+ T cells. (Q47576731) (← links)
- Biosynthesis and structure-activity relationships of the lipid a family of glycolipids (Q47641212) (← links)
- Danger signals: Chemotherapy enhancers? (Q47659090) (← links)
- Unique depot formed by an oil based vaccine facilitates active antigen uptake and provides effective tumour control (Q47699178) (← links)
- Heterovalent Glycodendrimers as Epitope Carriers for Antitumor Synthetic Vaccines. (Q48169265) (← links)
- Microneedle-Assisted, DC-Targeted Codelivery of pTRP-2 and Adjuvant of Paclitaxel for Transcutaneous Immunotherapy (Q48351402) (← links)
- Integration of nano drug-delivery system with cancer immunotherapy (Q48622958) (← links)
- C-Type Lectin-Like Receptors As Emerging Orchestrators of Sterile Inflammation Represent Potential Therapeutic Targets (Q50351148) (← links)
- Co-delivery of the NKT agonist α-galactosylceramide and tumor antigens to cross-priming dendritic cells breaks tolerance to self-antigens and promotes antitumor responses (Q50481937) (← links)
- Nanoparticles: augmenting tumor antigen presentation for vaccine and immunotherapy treatments of cancer. (Q52746279) (← links)
- Investigation of phosphorylated adjuvants co-encapsulated with a model cancer peptide antigen for the treatment of colorectal cancer and liver metastasis. (Q52777949) (← links)
- Autologous tumor cells/bacillus Calmette-Guérin/formalin-based novel breast cancer vaccine induces an immune antitumor response. (Q55002808) (← links)
- Identification of neoepitopes recognized by tumor-infiltrating lymphocytes (TILs) from patients with glioma. (Q55118347) (← links)
- Protein-based nanoparticles in Cancer vaccine development (Q57039785) (← links)
- β-glucans as potential immunoadjuvants: A review on the adjuvanticity, structure-activity relationship and receptor recognition properties (Q57167898) (← links)
- Virus-like particle vaccines: immunology and formulation for clinical translation (Q59353426) (← links)
- DAMP-Inducing Adjuvant and PAMP Adjuvants Parallelly Enhance Protective Type-2 and Type-1 Immune Responses to Influenza Split Vaccination (Q59791534) (← links)
- Activating the Nucleic Acid-Sensing Machinery for Anticancer Immunity (Q60175879) (← links)
- Vaccine Strategies to Improve Anti-cancer Cellular Immune Responses (Q61811648) (← links)
- Antigen Targets for the Development of Immunotherapies in Leukemia (Q64070843) (← links)
- Harnessing Dendritic Cells for Poly (D,L-lactide--glycolide) Microspheres (PLGA MS)-Mediated Anti-tumor Therapy (Q64071651) (← links)
- Vaccination with nanoparticles combined with micro-adjuvants protects against cancer (Q64086015) (← links)
- NLRP3 inflammasome-activating arginine-based liposomes promote antigen presentations in dendritic cells. (Q64916503) (← links)
- Updates in adjuvant systemic therapy for melanoma. (Q64954806) (← links)
- Augmenting Vaccine Immunogenicity through the Use of Natural Human Anti-rhamnose Antibodies (Q89148025) (← links)
- Computational Prediction and Validation of Tumor-Associated Neoantigens (Q89965571) (← links)
- An agonistic anti-Toll-like receptor 4 monoclonal antibody as an effective adjuvant for cancer immunotherapy (Q90085015) (← links)
- Development of N-Acetylated Dipalmitoyl-S-Glyceryl Cysteine Analogs as Efficient TLR2/TLR6 Agonists (Q90383914) (← links)
- Harnessing the untapped potential of nucleotide-binding oligomerization domain ligands for cancer immunotherapy (Q90481445) (← links)
- High Molecular Weight Chitosan-Complexed RNA Nanoadjuvant for Effective Cancer Immunotherapy (Q92051245) (← links)
- Novel Candidates for Vaccine Development Against Mycoplasma Capricolum Subspecies Capripneumoniae (Mccp)-Current Knowledge and Future Prospects (Q92150722) (← links)
- Extracellular vesicles derived from ODN-stimulated macrophages transfer and activate Cdc42 in recipient cells and thereby increase cellular permissiveness to EV uptake (Q92244167) (← links)
- Impact on antitumor response using a new adjuvant preparation as a component of a human papillomavirus type 16 therapeutic vaccine candidate (Q92471827) (← links)
- Immune adjuvant therapy using Bacillus Calmette-Guérin cell wall skeleton (BCG-CWS) in advanced malignancies: A phase 1 study of safety and immunogenicity assessments (Q92637440) (← links)
- Immunological effects of adjuvants in subsets of antigen presenting cells of cancer patients undergoing chemotherapy (Q92886110) (← links)
- Anti-glioma effect of intracranial vaccination with tumor cell lysate plus flagellin in mice (Q93199833) (← links)
- Comparison of personal and shared frameshift neoantigen vaccines in a mouse mammary cancer model (Q94547467) (← links)
- Immunostimulant Complexed with Polylysine Limits Transport and Maintains Immune Cell Activation (Q96603942) (← links)
- Targeted Co-delivery of Tumor Antigen and α-Galactosylceramide to CD141+ Dendritic Cells Induces a Potent Tumor Antigen-Specific Human CD8+ T Cell Response in Human Immune System Mice (Q99711565) (← links)
- Personalized Cancer Vaccines: Clinical Landscape, Challenges, and Opportunities (Q100513875) (← links)